Compounding MOUs
| MOU No. | Purpose | Parties | FDA Lead Center or Office/Contact |
Effective Date | Expiration Date |
Last Revision Date |
|---|---|---|---|---|---|---|
| 225-21-014 | This MOU describes the responsibilities of the Colorado Board of Pharmacy in investigating and responding to complaints related to drug products compounded in Colorado and distributed outside Colorado and in addressing the interstate distribution of inordinate amounts of compounded human drug products. |
Colorado Board of Pharmacy Patricia Evacko |
CDER / Office of Compliance / Office of Compounding Quality and Compliance Alexandria Fujisaki |
06-29-2021 | Indefinite | |
| 225-21-008 | This MOU establishes an agreement with the New Hampshire Office of Professional Licensure and Certification regarding the distribution of inordinate amounts of compounded human drug products interstate and the appropriate investigation by the New Hampshire Office of Professional Licensure and Certification of complaints relating to human drug products compounded in New Hampshire and distributed outside the state. | New Hampshire Office of Professional Licensure and Certification (OPLC) |
CDER / Office of Compliance / Office of Compounding Quality and Compliance F. Gail Bormel, Director |
03-18-2021 | Indefinite |